Current status of quality of life measurement in lung cancer patients.
AffiliationDepartment of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, UK.
MetadataShow full item record
AbstractQuality of life in patients with inoperable lung cancer receiving palliative treatment has become an important issue. As in other types of cancer, lack of standardization of quality of life data makes comparison between trials difficult, sometimes even impossible. Much effort is being given to the development of suitable instruments to measure quality of life and strategies to incorporate these measurements into clinical trials. The authors review studies in palliative lung cancer treatment where two crucial questions are being addressed: Do patients improve in performance status and symptom relief and does treatment toxicity outweigh disease palliation?
CitationCurrent status of quality of life measurement in lung cancer patients. 1991, 5 (5):159-166; discussion 166, 169, 173 Oncology
- Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise.
- Authors: Stephens RJ, Hopwood P, Girling DJ
- Issue date: 1999 Feb
- Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy.
- Authors: Gralla RJ, Thatcher N
- Issue date: 2004 Dec
- Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
- Authors: Numico G, Russi E, Merlano M
- Issue date: 2001 Jun
- The role of palliative care in the lung cancer patient: can we improve quality while limiting futile care?
- Authors: Freedman OC, Zimmermann C
- Issue date: 2009 Jul
- Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life.
- Authors: Gralla RJ
- Issue date: 2004